Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-28 @ 10:18 PM
Study NCT ID:
NCT06156332
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-05
First Post:
2023-11-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Sponsor:
Shanghai Changzheng Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-27
First Submit QC Date:
None
Study First Post Date:
2023-12-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-27
Last Update Post Date:
2023-12-05
Last Update Post Date Type:
ACTUAL